Medicine and Dentistry
Pediatrics
100%
Infection
88%
Disease
87%
Streptococcus Agalactiae
50%
Cohort Effect
45%
Group A Streptococcal Infection
35%
Necrotizing Fasciitis
34%
Health Care
32%
Pathogen
30%
Public Health
28%
Antibiotic Therapy
25%
Antifungal Therapy
25%
Antibiotics
23%
Neonatal Infant
21%
Antifungal Agent
20%
Serotype
19%
Cerebrospinal Fluid Shunting
19%
Pneumococcal Infection
19%
Systemic Candidiasis
19%
Neonatal Intensive Care Unit
19%
Healthcare Associated Infection
19%
Shunt Infection
19%
Health Care Provider
19%
Influenza Vaccine
19%
Bacterial Meningitis
19%
Meningitis
19%
Rabies
19%
Soft Tissue Infection
16%
Streptococcus Group A
16%
Septic Shock
15%
Outpatient
15%
Hypotension
14%
Primary Health Care
14%
Odds Ratio
14%
Virus Infection
14%
Neonate
14%
Health Care Cost
14%
Diabetes
13%
Influenza Vaccination
13%
Infection Control
13%
Case Fatality Rate
13%
Toxic Shock Syndrome
12%
COVID-19
12%
Sepsis
12%
Intensive Care Unit
12%
Ebolavirus
12%
Parenteral Drug Administration
12%
Beta Hemolytic Streptococcus
11%
Prematurity
11%
Household
10%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
53%
Streptococcus Group A
42%
Salmonellosis
28%
Infection
28%
Infectious Agent
28%
Vaccination Policy
26%
Group A Streptococcal Infection
25%
Necrotizing Fasciitis
22%
Salmonella
21%
Streptococcus Agalactiae
21%
Palivizumab
20%
Toxic Shock Syndrome
20%
Rotavirus
19%
Pneumococcal Infection
19%
Invasive Candidiasis
19%
Human Respiratory Syncytial Virus
19%
Bacterial Meningitis
19%
Antifungal Therapy
19%
Rabies
19%
Respiratory Syncytial Virus Infection
19%
Amphotericin B
17%
Antibiotics
15%
Antibiotic Agent
15%
Placebo
14%
Syndrome
14%
Chickenpox
14%
Diarrhea
12%
Hypotension
11%
Ampicillin
11%
Bronchiolitis
11%
Streptococcus Pneumoniae
11%
Pandemic
9%
Envenomation
9%
Bites and Stings
9%
Group B Streptococcal Infection
9%
Newborn Sepsis
9%
Urinary Tract Infection
9%
Bacteremia
9%
Invasive Aspergillosis
9%
Quinolone Derivative
9%
Healthcare Associated Infection
9%
Staphylococcal Infection
9%
Gastroenteritis
9%
Low Birth Weight
9%
Antifungal Agent
9%
Bursitis
9%
Recurrent Disease
9%
Short Course Therapy
9%
Pertussis
9%
Protein Antibody
9%
Keyphrases
Canada
32%
Michigan
28%
Salmonella Infection
25%
Non-typhoidal Salmonella
19%
Pediatric
19%
Hospitalization Risk
19%
Palivizumab Prophylaxis
19%
Group B Streptococcus
16%
Palivizumab
16%
Calgary
15%
Influenza Immunization
14%
Amphotericin B
14%
Pregnant Women
13%
Core Genome multilocus Sequence Typing (cgMLST)
13%
Young children
13%
Risk Factors
12%
Severe Group
12%
Hypotension
12%
Infectious Disease Specialist
12%
American Academy of Pediatrics
12%
Genetic Diversity
11%
Respiratory Syncytial Virus Hospitalization
10%
Salmonellosis
9%
Genital Infection
9%
CSF Shunt Infection
9%
Hospitalization Rate
9%
Community-acquired Pneumonia in children
9%
Capsular Genes
9%
Pharyngitis
9%
Microbiological Treatment
9%
Treatment Failure
9%
Economic Evaluation
9%
Sports Control
9%
Office Setting
9%
Virus Detection
9%
Immunocompromised Pediatric Patients
9%
Combination Antifungal Therapy
9%
Environmental Risk
9%
Late-onset Sepsis
9%
Draft Genome Sequence
9%
Canadian Perspective
9%
Rotavirus Gastroenteritis
9%
Childhood Fever
9%
Reimplantation
9%
Should Be Given
9%
Extended Reality
9%
University Departments
9%
Healthcare-associated Infections
9%
Dean's Office
9%
Study of Disease
9%
